Edition:
United States

Navidea Biopharmaceuticals Inc (NAVB.A)

NAVB.A on American Stock Exchange

0.45USD
4:02pm EDT
Change (% chg)

$-0.01 (-1.30%)
Prev Close
$0.46
Open
$0.45
Day's High
$0.46
Day's Low
$0.45
Volume
17,754
Avg. Vol
86,343
52-wk High
$1.14
52-wk Low
$0.26

NAVB.A

Chart for NAVB.A

About

Navidea Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. The Company is developing multiple precision-targeted products based on the Manocept platform to help identify the sites and pathways of undetected disease.... (more)
No analyst recommendations are available for NAVB.A.

Overall

Beta: -0.42
Market Cap(Mil.): $73.73
Shares Outstanding(Mil.): 161.90
Dividend: --
Yield (%): --

Financials

  NAVB.A Industry Sector
P/E (TTM): -- 142.93 17.37
EPS (TTM): -0.09 -- --
ROI: -- 2.34 -5.89
ROE: -- 0.22 -5.30

BRIEF-Navidea Biopharmaceuticals reports Q1 earnings $0.53/shr

* Navidea Biopharmaceuticals reports first quarter 2017 financial results

May 09 2017

BRIEF-Navidea Q4 loss per share $0.02

* Navidea provides corporate update and reports full year 2016 results

Mar 29 2017

BRIEF-Navidea Biopharmaceuticals files for non timely 10-K

* Navidea biopharmaceuticals files for non timely 10-k - sec filing

Mar 16 2017

BRIEF-Cardinal Health reports 5.8 pct passive stake in Navidea Biopharma

* Cardinal Health, Inc reports 5.8 percent passive stake in navidea biopharmaceuticals inc as of March 3, 2017 - sec filing Source text for Eikon: Further company coverage:

Mar 13 2017

BRIEF-Court entered interlocutory order declaring Navidea, Macrophage committed one or more events of default under loan agreement

* On Feb 9, court entered interlocutory order declaring Navidea, Macrophage committed one or more events of default under loan agreement

Feb 16 2017

BRIEF-Navidea Biopharmaceuticals enters asset purchase agreement with Cardinal Health

* Press release - Navidea signs asset purchase agreement with Cardinal Health

Nov 23 2016

More From Around the Web

Competitors

  Price Chg
General Electric Company (GE.N) $28.18 +0.13
Bayer AG (BAYGn.DE) €116.60 -0.35
Bayer AG (BAYE.F) -- --
Eli Lilly and Co (LLY.N) $76.98 -0.82

Earnings vs. Estimates